TELEPAQUE Drug Patent Profile
✉ Email this page to a colleague
When do Telepaque patents expire, and what generic alternatives are available?
Telepaque is a drug marketed by Ge Healthcare and is included in one NDA.
The generic ingredient in TELEPAQUE is iopanoic acid. There is one drug master file entry for this compound. Additional details are available on the iopanoic acid profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TELEPAQUE?
- What are the global sales for TELEPAQUE?
- What is Average Wholesale Price for TELEPAQUE?
Summary for TELEPAQUE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 80 |
| Patent Applications: | 1,528 |
| DailyMed Link: | TELEPAQUE at DailyMed |
US Patents and Regulatory Information for TELEPAQUE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ge Healthcare | TELEPAQUE | iopanoic acid | TABLET;ORAL | 008032-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
